XML 67 R45.htm IDEA: XBRL DOCUMENT v3.23.1
SHARE-BASED COMPENSATION - Narrative (Details)
12 Months Ended
Jan. 01, 2022
shares
Apr. 23, 2021
shares
Jan. 01, 2021
Dec. 31, 2022
USD ($)
equity-basedIncentivePlan
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Jun. 22, 2022
shares
Apr. 30, 2020
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of stock option plans | equity-basedIncentivePlan       3      
Expected term       10 years      
Sale of stock, extended option period   12 months          
Share-based compensation | $       $ 3,938,000 $ 2,413,000    
Total share-based compensation | $       $ 3,938,000 $ 2,413,000    
Capital shares reserved for future issuance (in shares)       30,893,290 2,470,890    
Options outstanding under the 2015 Stock Incentive Plan              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of options outstanding (in shares)       179,630 265,067    
Options granted (in shares)       0 0    
Intrinsic value of options exercised | $         $ 635,000    
Exercise of stock options (in shares)       0      
Fair value of stock option awards vested | $         49,000    
Options vested (in shares)       0      
Unrecognized compensation costs | $       $ 0      
Private Plan Option Modifications              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of options outstanding (in shares)   85,414          
Share-based compensation | $         $ 300,000    
Options outstanding under the 2012 Omnibus Incentive Plan, as amended              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of options outstanding (in shares)       1,192,233 730,377    
Options granted (in shares)       470,631      
Intrinsic value of options exercised | $         $ 39,000    
Exercise of stock options (in shares)       0      
Fair value of stock option awards vested | $       $ 3,700,000 800,000    
Unrecognized compensation costs | $       6,500,000      
Share-based compensation | $       $ 1,100,000 $ 100,000    
Purchase price of common stock, percent     5.00% 5.00%      
Number of additional shares authorized (in shares) 645,589            
Weighted-average grant date fair value of shares granted (in dollars per share) | $ / shares       $ 9.89 $ 18    
Weighted-average period for recognizing cost       2 years 7 months 6 days      
Capital shares reserved for future issuance (in shares)       565,120 273,940    
Options outstanding under the 2022 Stock Incentive Plan              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of options outstanding (in shares)       36,880 0    
Options granted (in shares)       36,880 0    
Exercise of stock options (in shares)       0      
Fair value of stock option awards vested | $       $ 22,000      
Unrecognized compensation costs | $       $ 100,000      
Weighted-average grant date fair value of shares granted (in dollars per share) | $ / shares       $ 3.64      
Weighted-average period for recognizing cost       2 years 6 months      
Capital shares reserved for future issuance (in shares)           600,000  
Options available for future grants (in shares)       565,120      
Minimum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period       3 years      
Maximum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period       4 years      
RDD Options              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Options granted (in shares)       0 0    
Intrinsic value of options exercised | $         $ 27,000    
Exercise of stock options (in shares)       0      
Employee Stock Option | Options outstanding under the 2012 Omnibus Incentive Plan, as amended              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Expected term       10 years      
RSUs | Options outstanding under the 2012 Omnibus Incentive Plan, as amended              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
RSUs granted (in shares)       0 0    
Nonvested number (in shares)       0      
Total share-based compensation | $       $ 0 $ 200,000    
RDD Pharma Ltd. | RDD Options              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of options outstanding (in shares)             50,714